APA (7th ed.) Citation

Klabukova, D. L., Holownia-Voloskova, M. E., Davydovskaya, M. V., Ermolaeva, T. N., Olyushina, E. M., Polyakova, K. I., . . . Kokushkin, K. A. (2018). Ocrelizumab in treatment of primary-progressive multiple sclerosis. Качественная клиническая практика, 2, 29. https://doi.org/10.24411/2588-0519-2018-10042

Chicago Style (17th ed.) Citation

Klabukova, D. L., M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, E. M. Olyushina, K. I. Polyakova, A. G. Fisun, M. G. Grinin, and K. A. Kokushkin. "Ocrelizumab in Treatment of Primary-progressive Multiple Sclerosis." Качественная клиническая практика 2 (2018): 29. https://doi.org/10.24411/2588-0519-2018-10042.

MLA (9th ed.) Citation

Klabukova, D. L., et al. "Ocrelizumab in Treatment of Primary-progressive Multiple Sclerosis." Качественная клиническая практика, 2, 2018, p. 29, https://doi.org/10.24411/2588-0519-2018-10042.